claim: oxford covid-19 failed to begin phase ii/iii human trials
evidence_1: mene pangalos, executive vice president, biopharmaceuticals r&d, astrazeneca said: 'we are so proud to be collaborating with the university of oxford to accelerate the development and globalisation of this potential new vaccine against covid-19 infection.